Rabeprazole PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Rabeprazole PCD pharma franchise company offering a portfolio of 21 Rabeprazole formulations across capsules, tablets, sachets and injection. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.

What is Rabeprazole?

Rabeprazole is a proton pump inhibitor (PPI). It binds the gastric H+/K+-ATPase enzyme on parietal cells and shuts down the final common step of acid secretion, producing sustained suppression of both basal and stimulated gastric acid. The compound record can be reviewed on PubChem.

Therapeutic Applications

Gastro-oesophageal reflux disease, erosive and non-erosive reflux, peptic and duodenal ulcer, NSAID-associated gastric injury, Helicobacter pylori eradication in combination with antibiotics, and pathological hypersecretory states such as Zollinger-Ellison syndrome. Fixed-dose combinations with prokinetics such as domperidone or levosulpiride are widely used for reflux with dysmotility.

Prescribed by: Gastroenterologists, general physicians, consulting surgeons and family doctors prescribe Rabeprazole most often; ENT and pulmonology consultants also use it for reflux-related cough and laryngitis.

Why Rabeprazole is a High-Potential Molecule for Distributors

Acid-peptic disease is one of the highest-volume prescription categories in India, and Rabeprazole has steadily displaced older PPIs in OPD practice because its activation is less dependent on CYP2C19 metabolism, making the response more predictable across patients. Courses typically run four to eight weeks and are frequently repeated, which converts into steady monthly offtake rather than one-off sales. With 21 formulations spanning capsules, tablets, sachets and injection, a distributor can serve OPD, hospital and combination-therapy demand from a single molecule.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers its Rabeprazole franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Rabeprazole business in your region.

References

1. PubChem – Rabeprazole compound record, US National Library of Medicine
2. PubMed – clinical literature on Rabeprazole, NCBI
3. WHO Model List of Essential Medicines